ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, published by WILEY, is a leading peer-reviewed journal dedicated to advancing the understanding of alcohol use and its clinical implications. With an impressive impact factor and categorized in the top quartile (Q1) in Medicine (miscellaneous), Psychiatry and Mental Health, and Toxicology, this journal serves a crucial role in disseminating high-quality research that informs clinical practice and health policy. The journal’s scope encompasses a wide range of topics related to alcohol use, including its effects on mental health, addiction, and public health, providing a vital platform for professionals, researchers, and students committed to enhancing knowledge in the field. The journal operates in the United States and is known for its rigorous editorial standards, ensuring that published articles contribute valuable insights to ongoing discussions in medicine and behavioral health. As of 2023-2024, the journal continues to thrive in a competitive academic landscape, aiming to foster collaboration and innovation in alcohol-related research.

The American Journal of Public Health, published by the American Public Health Association, stands as a cornerstone in the field of public health and epidemiology since its inception in 1949. With its rigorous peer-review process and a robust commitment to advancing knowledge and research practices, this journal holds a prestigious position in the academic community, as reflected in its 2023 Scopus ranking, where it is placed in the top percentile (93rd) within the categories of Public Health and Environmental and Occupational Health. The journal's focus encompasses a broad spectrum of public health topics, making it essential reading for researchers, practitioners, and students dedicated to improving population health. Subscribers can access invaluable insights through its collection of innovative studies and reviews, thereby reinforcing the journal's role in shaping public health policy and practice. By bridging research and real-world application, the American Journal of Public Health remains a vital resource for those engaged in the quest to improve health outcomes across diverse communities.

EXCLI Journal is an esteemed open access scientific publication dedicated to the fields of Animal Science and Zoology, Drug Discovery, Molecular Medicine, and Pharmacology. Established in 2002 and published by the EXCLI JOURNAL MANAGING OFFICE, this journal has quickly ascended in the academic community, securing a Q1 classification in significant categories like Animal Science and Drug Discovery in the 2023 rankings. With an impressive Scopus Rank of #13 out of 490 in its primary field, the journal maintains high standards for quality research and innovation. The EXCLI Journal is committed to disseminating progressive findings with global relevance, providing a platform for researchers, professionals, and students to engage with cutting-edge studies. With a compelling aim to foster knowledge exchange and collaboration among scientists worldwide, this journal signifies a critical resource for those invested in advancing our understanding of animal science and pharmaceutical research.

Alcohol Research-Current Reviews is a pivotal journal dedicated to advancing the understanding of alcohol-related issues and promoting scientific discourse in the fields of addiction and public health. Published by the National Institute on Alcohol Abuse and Alcoholism, this journal serves as a comprehensive platform that consolidates contemporary reviews on a wide array of topics related to alcohol, including its biological effects, societal implications, and prevention strategies. Despite its coverage in Scopus being discontinued, the journal remains a respected resource among researchers and practitioners, supporting the dissemination of important findings and fostering ongoing education in alcohol research. The open access option ensures that valuable research is readily available to an expansive audience, further enhancing the journal's impact in the academic community. With a ISSN of 1535-7414 and E-ISSN 1930-0573, the journal is committed to providing high-quality, peer-reviewed content that informs and influences public policy and health interventions.

JOURNAL OF DRUG ISSUES, published by SAGE PUBLICATIONS INC, serves as a pivotal platform for researchers and professionals dedicated to the multifaceted exploration of drug-related topics across various fields, including health, medicine, psychiatry, and public health. With an ISSN of 0022-0426 and an E-ISSN of 1945-1369, this esteemed journal has maintained a consistent output since its inception in 1971 and is set to continue its contributions through 2024. Reflecting its high academic standards, it has achieved a Q2 ranking in Health (Social Science) and Q3 rankings in several related categories, underscoring its relevance and influence among scholarly work. The journal is indexed in Scopus, with respectable rankings in various medical and health-related disciplines, highlighting its role as an essential resource for those invested in the vigorous discourse surrounding drug issues. Although not an open-access publication, the journal ensures that access to its extensive research findings remains available to a broad audience, solidifying its importance in advancing knowledge and informing best practices in the field.

Nordic Studies on Alcohol and Drugs is a leading peer-reviewed journal published by SAGE PUBLICATIONS LTD, dedicated to advancing the understanding of alcohol and drug use from a Nordic perspective. Established in 1989 and operating as an Open Access journal since 2011, it provides a platform for researchers and professionals in the fields of health policy and social sciences, focusing on empirical research and interdisciplinary studies. With a commendable 2023 Impact Factor, ranking Q2 in both Health Policy and Health (Social Science), it has carved a significant niche in the scholarly community, fostering discussions around public health and drug-related issues. The journal covers diverse topics relevant to the Nordic context, making it a valuable resource for those seeking to understand patterns of alcohol and drug consumption and their implications. The journal reaches an international audience, underscoring its relevance across national borders, and aims to facilitate collaboration and knowledge sharing among scholars, practitioners, and policymakers.

The JOURNAL OF CLINICAL PSYCHIATRY is a premier publication dedicated to advancing the understanding and treatment of psychiatric disorders. Established in 1978 and published by Physicians Postgraduate Press, this esteemed journal provides a vital platform for researchers, clinicians, and mental health professionals to share innovative findings and evidence-based practices in psychiatry. With an impressive impact factor and recognized as a Q1 journal in both Medicine (miscellaneous) and Psychiatry and Mental Health, the journal ranks among the top in its field, sitting at 96th out of 567 in Scopus rankings, placing it in the 83rd percentile. The journal's commitment to high-quality, peer-reviewed articles facilitates the dissemination of knowledge crucial for advancing clinical practices and improving patient outcomes. Access to its latest research is offered through institutional subscriptions, making it an essential resource for anyone involved in the mental health sector, from seasoned practitioners to aspiring students.

Welcome to the Harm Reduction Journal, a premier academic platform published by BMC, dedicated to advancing the field of harm reduction since its inception in 2004. With an impressive track record as an Open Access publication, this journal addresses critical topics within the broad scope of medicine, psychiatry, and public health, making it indispensable for researchers, healthcare professionals, and students alike. As of 2023, it proudly holds a Q1 ranking in prestigious categories including Medicine (Miscellaneous), Psychiatry and Mental Health, and Public Health, Environmental and Occupational Health, reflecting its high impact and significance in the academic community. The journal is notable for its comprehensive discussions on innovative harm reduction strategies, public policy considerations, and evidence-based practice, fostering collaboration and knowledge exchange. With a global reach and commitment to enhancing health outcomes, the Harm Reduction Journal serves as a vital resource in the ever-evolving landscape of public health and addiction research.

Substance Abuse Treatment, Prevention, and Policy is a premier open access journal published by BMC, dedicated to advancing the understanding and improvement of substance abuse treatment and prevention strategies. Since its inception in 2006, this journal has established itself as a significant resource in the fields of Health Policy and Psychiatry and Mental Health, proudly maintaining a strong reputation reflected in its 2023 Scopus rankings, which place it in the top quartiles of these categories. With an impactful focus on policy implications and evidence-based practices, the journal's comprehensive coverage supports the sharing of innovative research and perspectives aimed at mitigating substance abuse challenges worldwide. Open access since its launch, it ensures that vital research is readily available to researchers, practitioners, and students alike, facilitating collaboration and discourse in this critical area of public health. Its commitment to high-quality research is underscored by its rankings within the 78th percentile for Health Policy and 66th percentile for Psychiatry and Mental Health, highlighting its influence and relevance in addressing pressing issues in substance misuse.

Drug and Alcohol Dependence is a premier journal published by Elsevier Ireland Ltd, dedicated to the rigorous exploration and analysis of substance use disorders, including drug and alcohol dependencies. With its established history since 1975 and a remarkable convergence of research extending to 2024, the journal holds a prestigious position within the academic community, evidenced by its Q1 ranking in multiple categories, including Pharmacology, Psychiatry and Mental Health, and Toxicology for 2023. It ranks impressively among its peers, underscored by Scopus rankings of #46, #99, and #27 in key fields related to medical pharmacology and toxicology. As a non-open access title, it caters to a global readership of researchers, professionals, and students, providing them with peer-reviewed insights into critical developments and innovative methodologies in the field. The journal’s commitment to advancing knowledge and understanding of drug and alcohol dependence is essential for addressing the global challenges posed by substance use, making it a valuable resource for all stakeholders in public health and clinical practice.